Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nursing guidelines for muromonab-CD3 (OKT3).

M M Duffy, A Nestor

    ANNA Journal
    |October 1, 1992
    PubMed
    Summary
    This summary is machine-generated.

    Muromonab-CD3 helps prevent transplant graft rejection. Understanding nursing guidelines for dosage, side effects, and administration is crucial for effective use of this immunosuppressive therapy.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Arranging clinical affiliations.

    Journal for nurses in staff development : JNSD : official journal of the National Nursing Staff Development Organization·2003
    Same author

    Overcoming language barriers for non-English speaking patients.

    ANNA journal·2000
    Same author

    Designing a comprehensive hospital-wide patient education program.

    Advances in renal replacement therapy·1999
    Same author

    Can ED patients read your patient education materials?

    Journal of emergency nursing·1999
    Same author

    Mucosal metabolism in ulcerative colitis and Crohn's disease.

    Diseases of the colon and rectum·1998
    Same author

    Cross-sectional analysis of the relationship between national guideline recommended asthma drug therapy and emergency/hospital use within a managed care population.

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·1998
    Same journal

    Preserving the art of nephrology nursing.

    ANNA journal·2000
    Same journal

    Categorizing the response to Epoetin alfa therapy. Case study of the anemic patient.

    ANNA journal·2000
    Same journal

    Improving adequacy of dialysis: using in-series dialyzers.

    ANNA journal·2000
    Same journal

    Putting the pleasure back into eating for the elderly on a maintenance hemodialysis diet!

    ANNA journal·2000
    Same journal

    Does iron cause bacterial infections in patients with end stage renal disease?

    ANNA journal·2000
    Same journal

    Effects of psychosocial education on adaptation in elderly hemodialysis patients.

    ANNA journal·2000
    See all related articles

    Area of Science:

    • Immunology
    • Transplantation Medicine
    • Pharmacology

    Background:

    • Graft rejection remains a significant challenge in organ transplantation.
    • Muromonab-CD3 is an immunosuppressive monoclonal antibody used to manage graft rejection.
    • Effective nursing care is essential for optimizing muromonab-CD3 therapy.

    Purpose of the Study:

    • To provide a comprehensive overview of nursing implications for muromonab-CD3 administration.
    • To highlight key considerations for dosage, side effect management, and patient care.
    • To ensure safe and effective use of muromonab-CD3 in transplant recipients.

    Main Methods:

    • Literature review of current clinical practices and guidelines.
    • Analysis of pharmacokinetic and pharmacodynamic data.

    Related Experiment Videos

  • Synthesis of information on adverse event profiles and nursing interventions.

    • Main Results:

    • Muromonab-CD3 requires careful dosage titration and monitoring.
    • Common side effects include cytokine release syndrome and hypersensitivity reactions.
    • Specific nursing interventions are necessary to mitigate risks and manage adverse events.

    Conclusions:

    • Adherence to established nursing guidelines is vital for muromonab-CD3 efficacy.
    • Nurses play a critical role in monitoring patients and managing side effects.
    • Proper understanding and application of these guidelines improve outcomes for transplant patients receiving muromonab-CD3.